‘Open science’ paves new pathway to develop malaria drugs

Malaria remains one of the world’s leading causes of mortality in developing countries. Last year alone, it killed more than 400,000 people, mostly young children. An international consortium of researchers now unveils the mechanics and findings of a unique “open science” project for malaria drug discovery that has been five years in the making.